Researcher profile
Maria Patrizia Carrieri
Affiliations
Organizations
Aix-Marseille Universitéauthorship · FRARPE PACAauthorship · FRDélégation Paris 5authorship · FREconomic & Social Sciences, Health Systems & Medical Informaticsauthorship · FRHôpital Fochauthorship · FRInsermauthorship · FRInstitut de Recherche pour le Développementauthorship · FRInstitut de Recherche pour le Développementauthorship · BJObservatoire Régional de la Santé d’Alsaceauthorship · FRUniversité Paris Citéauthorship · FR
Public evidence
10 connected articles
Prevalence and factors associated with tobacco and cannabis co-use in France: Results from a national representative survey.2025 · Europe PMCAcceptability of and attitudes to the therapeutic use of cannabis and cannabidiol in people with Parkinson's disease: A French survey.2024 · Europe PMCExpanding Research on Cannabis-Based Medicines for Liver Steatosis: A Low-Risk High-Reward Way Out of the Present Deadlock?2023 · PubMed Central Open AccessCannabidiol use and perceptions in France: a national survey.2022 · Europe PMCCannabis Use Is Inversely Associated with Metabolic Disorders in Hepatitis C-Infected Patients (ANRS CO22 Hepather Cohort).2022 · PubMed Central Open AccessMedical Cannabis: Toward a New Policy and Health Model for an Ancient Medicine.2022 · PubMed Central Open AccessCannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort.2022 · PubMed Central Open AccessHCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data).2022 · PubMed Central Open AccessA "Good" Smoke? The Off-Label Use of Cannabidiol to Reduce Cannabis Use.2022 · Europe PMCCoffee Intake and Neurocognitive Performance in HIV/HCV Coinfected Patients (ANRS CO13 HEPAVIH).2020 · PubMed Central Open Access
Matched by exact identifiers only. Profile data: Corpus/OpenAlex.